Cubist Names Medical Chief

Dr. Lorianne Masuoka has been appointed chief medical officer and senior vice president of Clinical Development and Medical Affairs at Cubist Pharmaceuticals. She will also serve as a member of the executive team. Dr. Masuoka will lead the strategy, development and implementation of global clinical programs, as well as oversee Clinical Research, Medical Affairs, Clinical Operations, Biostatistics, Data Management, and Pharmacovigilance. 
 
Dr. Masuoka has more than 25 years of global medical and development experience, including serving as senior vice president, chief medical officer at Nektar Therapeutics, vice president of Clinical Development at Fiveprime Therapeutics, and director of Clinical Development at Chiron. She also held senior clinical positions at Schering AG and Berlex Laboratories.
 
“Dr. Masuoka brings to Cubist a great blend of medical and scientific leadership, diversity of therapeutic area experience, and global management skills,” said Steven Gilman, Ph.D., executive vice president of R&D and chief scientific officer of Cubist Pharmaceuticals. “She is a terrific addition to the Cubist team, and we’re very excited to have her join us as we drive towards our Building Blocks of Growth long-term goals.”